SCHEMBL22699151

SCHEMBL22699151

C/C(=C\c1cc2c(nc1C)CCCC2)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
SMN1; SMN2 Q16637 7/20 0.48
MAPT P10636 6/20 0.48
LMNA P02545 4/20 0.48
MAPK1 P28482 3/20 0.48
TP53 P04637 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 5/20 0.46
NR2F2 P24468 1/20 0.46
ATM Q13315 1/20 0.46
SLC9A1 P19634 1/20 0.46
HSP90AA1 P07900 1/20 0.44
KDM4E B2RXH2 6/20 0.40
NPC1 O15118 4/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
GRM1 Q13255 1/20 0.36
AKR1C3 P42330 1/20 0.34
EEF2K O00418 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837306 0.79 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL9837302 0.79 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL22699251 0.78 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL7910316 0.74 SLC9A1 (0.49) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL8132478 0.73 SLC9A1 (0.62) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL7910295 0.72 SLC9A1 (0.65) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL8260539 0.68 RAB9A (0.48) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL22699160 0.67 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL7910336 0.67 SLC9A1 (0.48) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1
SCHEMBL927885 0.66 SLC9A1 (0.60) ALDH1A1SMN1; SMN2MAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020236688-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES MERCK SHARP & DOHME CORP. (US) 2020-11-26 WO disclosed